Compare
Techprecision Corp vs Proto Labs Inc vs INNOVATE Corp. vs Arcosa, Inc.
| Latest fiscal year | Techprecision Corp TPCS | Proto Labs Inc PRLB | INNOVATE Corp. VATE | Arcosa, Inc. ACA |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $31.64M | $533.13M | $1.25B | $2.88B |
| Revenue growth (YoY) | -7.0% | +6.4% | +12.5% | +12.2% |
| Gross margin | 15.7% | 44.5% | 16.0% | 22.4% |
| Operating margin | -3.4% | 4.7% | 2.3% | 11.9% |
| Net margin | -5.3% | 4.0% | -4.9% | 7.2% |
| Net income | -$1.66M | $21.24M | -$60.60M | $208.40M |
| EPS (Diluted) | -$0.17 | $0.88 | -$4.84 | $4.24 |
| Operating cash flow | $6.0K | $74.50M | $146.60M | $341.10M |
| Free cash flow | -$3.26M | $59.66M | $146.10M | $175.50M |
| Cash & equivalents | n/a | $110.83M | $112.10M | $214.60M |
| Total assets | $32.27M | $763.41M | $950.10M | $4.99B |
| Total liabilities | $24.60M | $89.48M | $1.17B | $2.34B |
| Shareholders' equity | $7.67M | $673.93M | -$226.20M | $2.64B |
| Return on year-end equity | -21.7% | 3.2% | n/a | 7.9% |
| Shares outstanding | 10.02M | 23.63M | 13.66M | 49.00M |
Revenue, most recent five fiscal years
| Fiscal year | Techprecision Corp | Proto Labs Inc | INNOVATE Corp. | Arcosa, Inc. |
|---|---|---|---|---|
| Latest | $31.64M Ended 2026-03-31 | $533.13M Ended 2025-12-31 | $1.25B Ended 2025-12-31 | $2.88B Ended 2025-12-31 |
| 1 year earlier | $34.03M Ended 2025-03-31 | $500.89M Ended 2024-12-31 | $1.11B Ended 2024-12-31 | $2.57B Ended 2024-12-31 |
| 2 years earlier | $31.59M Ended 2024-03-31 | $503.88M Ended 2023-12-31 | $1.42B Ended 2023-12-31 | $2.31B Ended 2023-12-31 |
| 3 years earlier | $31.43M Ended 2023-03-31 | $488.40M Ended 2022-12-31 | $1.64B Ended 2022-12-31 | $2.24B Ended 2022-12-31 |
| 4 years earlier | $22.28M Ended 2022-03-31 | $488.10M Ended 2021-12-31 | $1.21B Ended 2021-12-31 | $2.04B Ended 2021-12-31 |